Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGBL2 | Q5U5Z8 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3394008 | 0.86 | ALDH1A1 (0.36) | AGBL2GABRR1KDM4EMEN1ALDH1A1 | |
| SCHEMBL8761522 | 0.70 | ALDH1A1 (0.33) | AGBL2ALDH1A1 | |
| SCHEMBL3395053 | 0.67 | ALDH1A1 (0.48) | MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL3389375 | 0.67 | CA2 (0.40) | ALDH1A1 | |
| SCHEMBL14338091 | 0.66 | ALDH1A1 (0.47) | KDM4EMEN1ALDH1A1GAAMAPT | |
| SCHEMBL1522878 | 0.65 | AKR1C3 (0.33) | — | |
| SCHEMBL8286626 | 0.64 | CA12 (0.45) | MEN1ALDH1A1KMT2A | |
| SCHEMBL17973028 | 0.60 | AGBL2 (0.43) | AGBL2GABRR1KDM4EALDH1A1MAPT | |
| SCHEMBL2434696 | 0.59 | MAPT (0.44) | AGBL2GABRR1KDM4EMEN1ALDH1A1 | |
| SCHEMBL25168224 | 0.59 | AGBL2 (0.51) | AGBL2GABRR1KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1560827-B1 | ANTI-INFECTIVE AGENTS | ABBOTT LAB (US) | 2010-12-29 | — | — | EP | disclosed |
| US-20050075331-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2005-04-07 | — | — | US | disclosed |
| US-20040167123-A1 | Anti-infective agents | ABBVIE INC. | 2004-08-26 | — | — | US | disclosed |
| US-20040162285-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2004-08-19 | — | — | US | disclosed |
| US-20040087577-A1 | Anti-infective agents | ABBOTT LABORATORIES | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040162285-A1 | Anti-infective agents | POLR1C, RPL5, POLB | AGBL2 1849/4885GABRR1 3425/4885KDM4E 4352/4885 |
| US-20040167123-A1 | Anti-infective agents | SERPINB1, CYP51A1, ZC3HAV1 | AGBL2 1903/4885GABRR1 3263/4885KDM4E 4075/4885 |
| US-20050075331-A1 | Anti-infective agents | RPL35, POLI, POLRMT | AGBL2 1163/4885GABRR1 3517/4885KDM4E 3897/4885 |
| US-20040087577-A1 | Anti-infective agents | POLR1C, RPL5, POLB | AGBL2 1849/4885GABRR1 3425/4885KDM4E 4352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.